ArticleBMC global and public health2025
CVD risk assessment by ethnicity in Aotearoa New Zealand: a national observational study.
Article in BMC global and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) risk assessment is a key strategy for reducing the burden of, and inequities in, CVD. The aim of this study was to determine whether there are inequities in CVD risk assessment by ethnicity in Aotearoa New Zealand (NZ).
methodsWe conducted a cross-sectional analysis of a de-identified national cohort of people aged 25-74 years living in NZ on 31 March 2018, recommended for CVD risk assessment according to current guidelines. The cohort was generated using both Statistics NZ's Integrated Data Infrastructure and health service user populations. People were excluded if they had a prior history of CVD. Univariable and multivariable logistic regression modelling was used to explore associations between ethnicity (Māori, Pacific, Indian, European or Other) and evidence of CVD risk assessment. We used national laboratory claims between 1 April 2018 and 31 March 2023 to find tests related to CVD risk assessment as a proxy for completed assessments.
results1,476,747 people (40.5% women, 12.1% with diabetes) were eligible for CVD risk assessment on 31st March 2018. Overall, 67.1% of eligible men (88.9% of those with diabetes) and 65.5% of women (86.3% of those with diabetes) had tests required for a CVD risk assessment between 1 April 2018 and 31 March 2023. This proportion varied by ethnicity, from 62.3% among Māori to 65.7% among European, 69.8% Other, 69.9% Pacific and 80.3% among Indian Peoples. The odds of CVD risk assessment after adjustment for socioeconomic deprivation and residential district were lower for Māori men (adjusted OR, aOR, 0.77 (0.72-0.83) with diabetes, 0.73 (0.72-0.74) without diabetes) and women (aOR 0.93 (0.87-0.99) with diabetes, 0.89 (0.87-0.91) without diabetes) compared with Europeans. Pacific men also had significantly lower odds of CVD risk assessment compared with Europeans (aOR 0.86 (0.78-0.94) with diabetes, 0.72 (0.70-0.74) without diabetes), as did Pacific women without diabetes (aOR 0.95 (0.92-0.98)). Indian people with and without diabetes had significantly higher odds (aOR 1.2-1.7) of CVD risk assessment compared with Europeans.
conclusionsWe found Māori and Pacific Peoples experienced inequities in CVD risk assessment. There is a critical need for strategies that eliminate inequities for these underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.